Molecular testing revealed a clonal immunoglobulin heavy chain (IGH) gene rearrangement, suggesting that PCNSHS may have transformed from the patient’s prior B-ALL (26). This evidence concerns the gene SLC3A2 and acute lymphoblastic leukemia.